(NASDAQ)
6.78
+0.21   (+3.20%)
 
Volume (24h) Market Cap. Day Range 52w Range
227.89K 135.99M 6.47 - 6.87 2.25 - 15.83
Jan-14-21 07:00AM Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test SystemsGlobeNewswire
Dec-17-20 04:05AM Chembio Diagnostics Appoints David Acheson, M.D. to its Board of DirectorsGlobeNewswire
Dec-05-20 02:15AM Is Chembio Diagnostics (NASDAQ:CEMI) Using Too Much Debt?Simply Wall St.
Dec-04-20 08:49AM Are Options Traders Betting on a Big Move in Chembio Diagnostics (CEMI) Stock?Zacks
Dec-03-20 08:48AM Chembio Diagnostics (CEMI) Surges: Stock Moves 8.5% HigherZacks
Dec-02-20 01:22AM Chembio Diagnostics Awarded $12.7 Million by BARDA for Development of Rapid DPP Respiratory Antigen Panel and 510(k) Submission of the Rapid DPP SARS-CoV-2 Antigen Test SystemGlobeNewswire
Nov-27-20 01:10AM Is Chembio Diagnostics Inc (CEMI) A Good Stock To Buy?Insider Monkey
Nov-13-20 04:40AM Chembio Diagnostics Receives ANVISA Approval for DPP SARS-CoV-2 Antigen Test System in BrazilGlobeNewswire
Nov-05-20 04:05AM Chembio Diagnostics Reports Third Quarter 2020 Financial ResultsGlobeNewswire
02:30AM Chembio Diagnostics, Inc. to Host Earnings CallACCESSWIRE
Oct-23-20 08:00AM Chembio Diagnostics to Report Third Quarter 2020 Financial Results on November 5, 2020GlobeNewswire
Oct-16-20 07:15AM The Daily Biotech Pulse: Amarin Vascepa Data, Galapagos Osteoarthritis Drug Update, 4 IPOsBenzinga
Oct-15-20 05:55AM Chembio Diagnostics Submits EUA Application for DPP SARS-CoV-2 Antigen Test SystemGlobeNewswire
Oct-06-20 08:38AM Introducing Chembio Diagnostics (NASDAQ:CEMI), A Stock That Climbed 18% In The Last Five YearsSimply Wall St.
Oct-02-20 10:10AM Return On Capital Employed Overview: Chembio DiagnosticsBenzinga
07:26AM Chembio Diagnostics Receives FDA Approval for DPP HIV-Syphilis SystemGlobeNewswire
Sep-25-20 08:55AM Implied Volatility Surging for Chembio (CEMI) Stock OptionsZacks
Sep-08-20 06:00AM Chembio Submits EUA Application for New DPP SARS-CoV-2 IgM/IgG Test SystemGlobeNewswire
Aug-25-20 08:57AM Are Options Traders Betting on a Big Move in Chembio Diagnostics (CEMI) Stock?Zacks
Aug-17-20 02:15AM CLASS ACTION UPDATE for ENPH, CEMI and BKD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersACCESSWIRE
11:50AM DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Chembio Diagnostics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile
Aug-17-20 11:40AM SHAREHOLDER ALERT: ENPH CEMI CODX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action DeadlinesACCESSWIRE
11:01AM CEMI FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Chembio Diagnostics, Inc. and Lead Plaintiff Deadline: August 17, 2020ACCESSWIRE
Aug-17-20 07:30AM SHAREHOLDER ALERT: PRA ENPH CEMI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action DeadlinesACCESSWIRE
06:55AM SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Chembio Diagnostics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 17, 2020 - CEMINewsfile
Aug-16-20 03:09AM CEMI DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Chembio Diagnostics, Inc. and Lead Plaintiff Deadline: August 17, 2020ACCESSWIRE
11:44AM DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Chembio Diagnostics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile
Aug-16-20 10:51AM CLASS ACTION UPDATE for CEMI, KL and JCOM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersACCESSWIRE
Aug-15-20 02:35AM FINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Chembio Diagnostics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmACCESSWIRE
Aug-14-20 03:55AM SHAREHOLDER ALERT: CEMI CODX KL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action DeadlinesACCESSWIRE
02:25AM IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Chembio Diagnostics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmACCESSWIRE
Aug-14-20 01:00AM CEMI DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Chembio Diagnostics, Inc. and Lead Plaintiff Deadline: August 17, 2020Newsfile
12:00PM The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Chembio Diagnostics, Inc. (CEMI)Business Wire
Aug-14-20 10:00AM CEMI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 17, 2020 in the Class Action Filed on Behalf of Chembio Diagnostics, Inc. Limited ShareholdersNewsfile
09:31AM MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Chembio Diagnostics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile
Aug-14-20 08:30AM DEADLINE ALERT: Kaskela Law LLC Announces Important Deadline in Shareholder Class Action Lawsuit Filed Against Chembio Diagnostics, Inc. (CEMI) and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmPR Newswire
Aug-13-20 06:10AM FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Chembio Diagnostics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmACCESSWIRE
02:25AM The Gross Law Firm Announces Class Actions on Behalf of Shareholders of NSP, CEMI and JCOMACCESSWIRE
Aug-13-20 01:45AM CEMI FINAL DEADLINE: ROSEN, A TOP FIRM, Encourages Chembio Diagnostics, Inc. Investors to Contact Firm Before Important August 17 Deadline in Securities Class Action Seeking Recovery of Losses- CEMIACCESSWIRE
12:45PM CLASS ACTION UPDATE for TUFN, CEMI and JCOM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersACCESSWIRE
Aug-13-20 11:31AM INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Chembio Diagnostics, Inc.Business Wire
10:30AM The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CEMI, ERII and GWREACCESSWIRE
Aug-13-20 09:47AM MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Chembio Diagnostics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile
Aug-12-20 04:45AM Lawsuits Filed Against CEMI, CSPR and CODX - Jakubowitz Law Pursues Shareholders ClaimsACCESSWIRE
04:11AM DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Chembio Diagnostics, Inc. and Encourages Investors to Contact the FirmBusiness Wire
Aug-12-20 03:27AM DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Chembio Diagnostics, Inc.ACCESSWIRE
03:15AM The Gross Law Firm Announces Class Actions on Behalf of Shareholders of PRA, CEMI and CODXACCESSWIRE
Aug-12-20 02:40AM SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Chembio Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline - CEMIACCESSWIRE
12:35PM The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CEMI, IDEX and GEOACCESSWIRE
Aug-12-20 11:59AM Chembio Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Chembio Diagnostics, Inc. To Contact The FirmNewsfile
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or monitor diseases. It offers tests for HIV and Syphilis, and Zika virus. The company also develops tests for malaria, Dengue virus, chikungunya virus, Ebola, Lassa, Marburg, leptospirosis, Rickettsia typhi, Burkholderia pseudomallei, and Orientia tsutsugamushi. It sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, or DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has collaboration agreements with Concussion Science Group Division of Perseus Science Group LLC for the development of a POC diagnostic test for traumatic brain injury; international diagnostics company to develop a POC diagnostic test for a specific type of cancer; and AstraZeneca for the development of a POC assay for a novel biomarker, as well as with LumiraDx to develop POC diagnostic tests. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Medford, New York.
Cap:    |  Volume (24h):